Background: Cell membrane composition and fluidity are altered in hypertension. Previous reports suggest arachidonic acid, a metabolically active fatty acid, is increased in the membranes of hypertensive animals compared to control. This increase in unsaturated fatty acids does not explain the observed reduction in fluidity in hypertensive rats, suggesting some other factors affecting fluidity may be present. It has been suggested that the metabolism of sphingomyelin is altered in genetic hypertension. We hypothesized that membrane sphingomyelin content is increased in hypertensive animals. Procedures: Stroke-prone spontaneously hypertensive rats (n ϭ 8) were compared with Wistar-Kyoto rats (n ϭ 8). Erythrocyte membranes were prepared and the lipids extracted and separated. Fatty acid methyl esters were produced, identified, and quantified by gas chromatography-mass spectrometry; membrane lipid content was also assessed.
M
embrane fluidity is reduced in hypertension as indicated by an increase in membrane microviscosity. [1] [2] [3] [4] [5] [6] [7] [8] There are a variety of possible causes of reduced fluidity, which include a reduction in membrane unsaturated fatty acid and an increase in the amount of long chain saturated fatty acids. An increase in the amount of protein or cholesterol present in the membrane would have a similar affect. Alternatively, the lipid composition of the membrane could be altered, thereby affecting fluidity. A lipid known to reduce membrane fluidity is sphingomyelin. This lipid contains both an amide bond and a trans double bond that, in addition to the high proportion of bound long chain saturated fatty acids, cause a reduction in membrane fluidity. 9 Previous studies of cell membrane composition in hypertension have been confined to analysis of fatty acids. Dominiczak et al 8 reported an increase in the proportion of arachidonic acid in cultured vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats (SHRSP) as compared to Wistar-Kyoto (WKY) rats. Similar changes have been observed in erythrocyte membranes from patients with essential hypertension. 10 Naftilan et al 5 observed that the platelet membranes from patients with essential hypertension have less membrane linoleic acid and a small, but insignificant, increase in the amount of arachidonic acid present in the membranes from these patients. Because unsaturated fatty acids cause the membrane to become more fluid, this cannot account for the reduced membrane fluidity observed in hypertension. Other studies have suggested that cells from the aorta and kidney from SHR contain less unsaturated fatty acids than those from WKY rats. Also the chain length of the fatty acids were significantly shorter in the SHR than the WKY rats. 11 Thus, a more comprehensive study of the cell membrane was necessary.
Recently, interest has increased in a novel signaling pathway in vascular smooth muscle cells, the ceramide signaling pathway. Ceramide is produced in the cell by hydrolysis of sphingomyelin by the membrane associated sphingomyelinase. 12 This hydrolysis can be stimulated by cytokines such as tumor necrosis factor-␣. 13 Studies have shown that cultured vascular smooth muscle cells from normotensive rats have lower basal and stimulated ceramide synthesis than hypertensive rats.
14 A possible mechanism for this could be a reduction in the activity of the membrane sphingomyelinase, which may result in an increase in the amount of sphingomyelin in the membrane.
We hypothesized that there is a general alteration in the metabolism of sphingomyelin in the hypertensive rats and that this results in an increase in membrane sphingomyelin.
Methods

Animals
Male SHRSP and WKY rats were obtained from a breeding colony in the Department of Medicine & Therapeutics, University of Glasgow. They were housed two to a cage and maintained on a 12-h light-dark cycle; water and normal rat chow were available ad libitum. The experiments were approved by the Home Office according to regulations regarding experiments with animals in the United Kingdom (these meet the requirements of the American Physiological Society).
Analysis of Membrane Lipids
Membrane lipids were analyzed as previously described. 15 Briefly, membrane protein was measured using the method of Lowry et al 16 and membrane lipids were extracted from membrane containing 2 mg of protein following the method of Floch et al. 17 Lipids were then separated using a combination of silica Sep-paks and thin layer chromatography. Fatty acid methyl esters were produced by acid-catalyzed transesterification and were analyzed and quantified by gas chromatography-mass spectrometry. Concentration of membrane phospholipids was calculated using the method of Seewald and Eichinger. 18 The following lipids were studied: phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol, lysophosphatidylcholine, sphingomyelin, cholesterol esters, free fatty acids, triglycerides, and partical glycerides. The following fatty acids were measured for each lipid group and the total lipid groups: palmitic 
Statistical Analyses
The fatty acid profiles for each lipid were analyzed by two-way analysis of variance, where this was found to be significant; differences between individual fatty acids were analyzed by Student's t test. This method of statistical analysis for membrane lipid composition has been described previously 15 and takes into account the large number of data points generated by this method.
Results
Derived Phospholipid Composition
Analysis of membrane phospholipid composition showed no difference in the levels of phosphatidylcholine, phosphatidylinositol, phosphatidylserine, or lysophosphatidylcholine. There was a significant increase in the level of the membrane sphingomyelin in the SHRSP compared to WKY rats (45.7 Ϯ 6 v 22.4 Ϯ 2 g/mg protein; P Ͻ .05). Fig. 1 shows the differences in the total fatty acid composition of the erythrocyte membranes from SHRSP and WKY rats. Palmitic, linoleic, stearic, arachidonic, dihomo-␥-linolenic, docosahexaenoic, behenic, lignoceric, and hexacosanoic acid were all significantly higher in the
Total Fatty Acid Composition
Membrane fatty acid composition in SHRSP and WKY rats (n ϭ 8 for both groups). The fatty acids composition was first assessed by ANOVA and was deemed to be different between the two groups, the individual fatty acids were then studied by t test, only those found to be significantly different from control are shown here (P Ͻ .05). Palmitic, linoleic, stearic, arachidonic, dihomo-␥-linolenic, docosahexaenoic, behenic, lignoceric, and hexacosanoic acid were all significantly higher in the erythrocyte membranes from SHRSP compared to the WKY. SHRSP ϭ stroke-prone spontaneously hypertensive rats; WKY ϭ Wistar-Kyoto rats.
erythrocyte membranes from SHRSP compared to the WKY rats. The following fatty acids were not different between the two groups: palmitoleic, linolenic, oleic, and arachidic acid. When the fatty acid composition of the individual lipid groups was studied the increase in arachidonic acid was only observed in the free fatty acid and phosphatidylinositol fraction (Fig. 2) . The following lipid groups were found to be significantly different by ANOVA between the SHRSP and WKY rats: cholesterol esters, free fatty acids, partial glycerides, phosphatidylethanolamine, sphingomyelin, and phosphatidylinositol. The changes in the fatty acid composition of these lipid groups are outlined in Table 1 (only fatty acids that were found to be significantly different by a post-hoc t test are shown). It should be noted that the increase in arachidonic acid in the membrane cannot be accounted for by only phosphatidylinositol (PI) and free fatty acid (FFA). There was an increase in the arachidonic acid content of phosphatidylcholine (22.501 Ϯ 2.357 v 12.965 Ϯ 0.992 ng/mg of protein SHRSP v WKY rats); however, the ANOVA comparing the fatty acids from SHSRP and WKY rats was insignificant.
Discussion
Changes in the fatty acid composition of the cell membrane may have a direct effect on its function or may affect it indirectly by modifying its physical properties. The importance of these changes will vary depending on which lipid group they occur in and in which membrane leaflet these lipids are situated. Changes in membrane fluidity affect cells in different ways; reduced fluidity in erythrocytes will affect cell deformability, impairing the cell's ability to pass through small capillaries. When studying the pathogenesis of hypertension, it would be most rele- 8 Thus, we can speculate that similar changes to those observed here, in erythrocytes, will also occur in vascular smooth muscle cells and other cardiovascular cell types.
There were two main findings of this study: the concentration of sphingomyelin present in the membrane is increased in the genetically hypertensive rats, the previously reported increase in membrane arachidonic acid content was limited to phosphatidylinositol and free fatty acid lipid types. The increase in membrane sphingomyelin content may have implications for both membrane fluidity and cell signaling. The structure of sphingomyelin is unlike other membrane phospholipids, it contains an amide bond and long chain saturated fatty acids, both of which are thought to contribute to the ability to reduce membrane fluidity. 9 The gross changes in membrane fatty acids suggest that, if membrane fluidity is a function of fatty acids alone, the membrane from the hypertensive animals would be in fact more fluid as most of the fatty acids that are increased in the hypertensive animals were unsaturated. Also, the membrane cholesterol content was not different between the two strains suggesting that something else must be responsible for the changes in membrane fluidity (data not shown). It is possible that sphingomyelin is responsible for the change in fluidity. Other studies have shown that by decreasing the phosphatidylcholine/sphingomyelin ratio or by increasing membrane sphingomyelin, it is possible to reduce membrane fluidity. 9, 19 It is possible that the increase in the amount of membrane sphingomyelin is an effect of the previously reported reduction in the membrane-bound sphingomyelinase activity in genetic hypertension.
14 Sphingomyelinase is activated by cytokines to cause the production of phosphocholine and the vasodilator ceramide, 11 thus removing ceramide from the membrane. In this situation of reduced enzyme activity the amount of sphingomyelin present in the membrane may increase and the amount of vasodilating ceramide would be reduced, further exacerbating the hypertension. There are no reports in the literature to confirm that erythrocytes possess sphingomyelinase activity. Nonetheless, the increase in membrane sphingomyelin content may reflect an overall change in the metabolism of this lipid. The lipids present in the red cell membrane are in a constant dynamic state with those in plasma. Thus, even if no enzyme is present in erythrocytes, this change may reflect an increase in sphingomyelin production or a reduction in its metabolism. Recent evidence that cer-
FIG. 2.
Arachidonic acid content of the phosphatidylinositol fraction (PI) and the free fatty acid fraction (FFA) from SHRSP and WKY rats (n ϭ 8 for both groups). Results were analyzed by t test, * P Ͼ .05. The arachidonic acid content of all other lipids groups was not different between the two strains. Other abbreviations as in Fig. 1 . amide signaling is altered in hypertension 14 suggests the latter may be the case.
The second interesting observation from this study was that the previously observed increase in membrane arachidonic acid content is limited to two lipid groups, PI and FFA, although there were no differences in the total amount of either lipid group. Arachidonic acid is a major constituent of PI, from which it is released in response to activation of many cell membrane receptors. It is the precursor of prostaglandins, leukotrienes, thromboxanes, and other P450 metabolites that are variously vasoconstrictors and vasodilators. Changes in the balance of these constituents may affect blood pressure. This may lead to an increase in the release of vasoactive compounds in the hypertensive animals. The increase in the amount of arachidonic acid present in the membrane cannot be solely attributed to the increases in the amount present in PI and FFA. There were small increases in the other lipid groups, but these groups did not return a statistically significant ANOVA.
Arachidonic acid and other polyunsaturated fatty acids inhibit gene transcription 20 -22 by affecting the activity of transcription factors that target cis-linked elements associated with specific genes. 23 The increase in the amount of arachidonic acid in the free fatty acid fraction is of particular interest. Free fatty acids diffuse freely in and out of the membrane and are at best a "snap-shot" of the composition of the plasma. Thus, higher free fatty acid levels reflect higher plasma levels. It is possible that arachidonic acid is acting at the level of gene transcription in hypertension. Interestingly, free arachidonic acid is also thought to directly activate potassium channels in smooth muscle cells. 24 If similar changes to those observed here also occur in vascular smooth muscle cells, the changes observed in the current experiments could contribute to altered vascular function.
These results add significantly to our knowledge of membrane abnormalities in hypertension. The increase in membrane sphingomyelin observed plays a role in the altered membrane fluidity observed in hypertension. It may also reflect a more general decrease in sphingomyelin metabolism and reduced ceramide synthesis. Also the finding of increased membrane arachidonic acid is in itself not new but that change only occurs in two very dynamic lipid groups.
